Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Bidoli

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
The International Journal of Biological Markers|January 1, 1993
Chronic effects of subcutaneous interleukin-2 therapy on soluble interleukin-2 receptors in advanced small cell lung cancerS Viviani, P M Salvini, P Bidoli, et al.
Tumori|February 28, 1989
Surgical resection in the treatment of stages I-II of small cell lung carcinoma (SCLC)I Cataldo, A V Bedini, G Muscolino, et al.
Cancer|August 22, 2000
Gemcitabine plus vinorelbine as first-line chemotherapy in advanced nonsmall cell lung carcinoma a phase II trialE Bajetta, S Chiara Stani, D De Candis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2000
Tumor response and estrogen suppression in breast cancer patients treated with aromatase inhibitorsE Bajetta, N Zilembo, E Bichisao, et al.
Tumori|March 18, 1999
Nutritional support in patients with cancer of the esophagus: impact on nutritional status, patient compliance to therapy, and survivalF Bozzetti, L Cozzaglio, C Gavazzi, et al.
Tumori|December 31, 1991
Effect of prolonged subcutaneous administration of interleukin-2 on the circadian rhythms of cortisol and beta-endorphin in advanced small cell lung cancer patientsS Spinazzé, S Viviani, P Bidoli, et al.
Rays|July 1, 1993
Combined radiation and chemotherapy in esophageal cancerR Zucali, P Bidoli, P M Salvini, et al.
Seminars in Oncology|February 1, 1995
A summary of the Milan experience with multimodality therapies in patients with small cell lung cancer: attempts to improve long-term outcomeA Santoro, H S Parra, P Bidoli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 4, 2003
Preclinical and clinical evaluation of four gemcitabine plus carboplatin schedules as front-line treatment for stage IV non-small-cell lung cancerE Bajetta, S C Stani, D De Candis, et al.
British Journal of Cancer|January 11, 2007
Evidence for PDGFRA, PDGFRB and KIT deregulation in an NSCLC patientT Negri, P Casieri, F Miselli, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
The International Journal of Biological Markers|January 1, 1993
Chronic effects of subcutaneous interleukin-2 therapy on soluble interleukin-2 receptors in advanced small cell lung cancerS Viviani, P M Salvini, P Bidoli, et al.
Tumori|February 28, 1989
Surgical resection in the treatment of stages I-II of small cell lung carcinoma (SCLC)I Cataldo, A V Bedini, G Muscolino, et al.
Cancer|August 22, 2000
Gemcitabine plus vinorelbine as first-line chemotherapy in advanced nonsmall cell lung carcinoma a phase II trialE Bajetta, S Chiara Stani, D De Candis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2000
Tumor response and estrogen suppression in breast cancer patients treated with aromatase inhibitorsE Bajetta, N Zilembo, E Bichisao, et al.
Tumori|March 18, 1999
Nutritional support in patients with cancer of the esophagus: impact on nutritional status, patient compliance to therapy, and survivalF Bozzetti, L Cozzaglio, C Gavazzi, et al.
Tumori|December 31, 1991
Effect of prolonged subcutaneous administration of interleukin-2 on the circadian rhythms of cortisol and beta-endorphin in advanced small cell lung cancer patientsS Spinazzé, S Viviani, P Bidoli, et al.
Rays|July 1, 1993
Combined radiation and chemotherapy in esophageal cancerR Zucali, P Bidoli, P M Salvini, et al.
Seminars in Oncology|February 1, 1995
A summary of the Milan experience with multimodality therapies in patients with small cell lung cancer: attempts to improve long-term outcomeA Santoro, H S Parra, P Bidoli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 4, 2003
Preclinical and clinical evaluation of four gemcitabine plus carboplatin schedules as front-line treatment for stage IV non-small-cell lung cancerE Bajetta, S C Stani, D De Candis, et al.
British Journal of Cancer|January 11, 2007
Evidence for PDGFRA, PDGFRB and KIT deregulation in an NSCLC patientT Negri, P Casieri, F Miselli, et al.
Pageof 4